758 related articles for article (PubMed ID: 16288186)
1. Systemic and organ dysfunction response during infusion of recombinant human activated protein C (rhAPC) in severe sepsis and septic shock.
Gullo A; Iscra F; Di Capua G; Berlot G; Lucangelo U; Peratoner A; Fasiolo S; Viviani M; Consales C; Zicari A
Minerva Anestesiol; 2005 Dec; 71(12):785-801. PubMed ID: 16288186
[TBL] [Abstract][Full Text] [Related]
2. Early goal-directed therapy, corticosteroid, and recombinant human activated protein C for the treatment of severe sepsis and septic shock in the emergency department.
Nguyen HB; Corbett SW; Menes K; Cho T; Daugharthy J; Klein W; Wittlake WA
Acad Emerg Med; 2006 Jan; 13(1):109-13. PubMed ID: 16365336
[TBL] [Abstract][Full Text] [Related]
3. [Use of protein C concentrate in adult patients with severe sepsis and septic shock].
Baratto F; Michielan F; Gagliardi G; Di Gregorio G; Pasqualetto A; Meroni M; Giron GP
Minerva Anestesiol; 2004 May; 70(5):351-6. PubMed ID: 15181415
[TBL] [Abstract][Full Text] [Related]
4. Hemodynamic effects of recombinant human activated protein C in patients with septic shock.
Sanchez B; Piacentini E; Pradella V; Mignini M; Nava J
J Crit Care; 2010 Jun; 25(2):343-7. PubMed ID: 19781904
[TBL] [Abstract][Full Text] [Related]
5. Elevated plasma concentrations of IL-6 and elevated APACHE II score predict acute kidney injury in patients with severe sepsis.
Chawla LS; Seneff MG; Nelson DR; Williams M; Levy H; Kimmel PL; Macias WL
Clin J Am Soc Nephrol; 2007 Jan; 2(1):22-30. PubMed ID: 17699383
[TBL] [Abstract][Full Text] [Related]
6. Use of activated protein C in liver transplantation patients with septic shock.
Rinaldi L; Marietta M; Mignini MA; Donno L; Busani S; Codeluppi M; Masetti M; Girardis M
Liver Transpl; 2008 Nov; 14(11):1598-602. PubMed ID: 18972572
[TBL] [Abstract][Full Text] [Related]
7. Platelet aggregation and blood rheology in severe sepsis/septic shock: relation to the Sepsis-related Organ Failure Assessment (SOFA) score.
Alt E; Amann-Vesti BR; Madl C; Funk G; Koppensteiner R
Clin Hemorheol Microcirc; 2004; 30(2):107-15. PubMed ID: 15004335
[TBL] [Abstract][Full Text] [Related]
8. [Study the effects of high-volume hemofiltration and fluid resuscitation on removing blood lactic acid and pro-inflammatory cytokines in patients with refractory septic shock].
Wang CT; Ren HS; Jiang JJ; Zhang JC; Meng M; Yu JB; Chu YF; Ding M
Zhongguo Wei Zhong Bing Ji Jiu Yi Xue; 2009 Jul; 21(7):421-4. PubMed ID: 19615135
[TBL] [Abstract][Full Text] [Related]
9. [Early changes in function of hypothalamic-pituitary-target gland axis in patients with severe sepsis and septic shock].
Cui N; Liu DW; Wang H; Zeng ZP; Long Y; Chai WZ; Liu HZ; Wang XT
Zhongguo Wei Zhong Bing Ji Jiu Yi Xue; 2007 Jun; 19(6):332-5. PubMed ID: 17577436
[TBL] [Abstract][Full Text] [Related]
10. [APACHE II, APACHE III, SOFA scoring systems, platelet counts and mortality in septic and nonseptic patients].
Balci C; Sungurtekin H; Gürses E; Sungurtekin U
Ulus Travma Acil Cerrahi Derg; 2005 Jan; 11(1):29-34. PubMed ID: 15688265
[TBL] [Abstract][Full Text] [Related]
11. Survival analysis of 314 episodes of sepsis in medical intensive care unit in university hospital: impact of intensive care unit performance and antimicrobial therapy.
Degoricija V; Sharma M; Legac A; Gradiser M; Sefer S; Vucicević Z
Croat Med J; 2006 Jun; 47(3):385-97. PubMed ID: 16758516
[TBL] [Abstract][Full Text] [Related]
12. Efficacy of therapy with recombinant human activated protein C of critically ill surgical patients with infection complicated by septic shock and multiple organ dysfunction syndrome.
Barie PS; Hydo LJ; Shou J; Eachempati SR
Surg Infect (Larchmt); 2011 Dec; 12(6):443-9. PubMed ID: 22185191
[TBL] [Abstract][Full Text] [Related]
13. [Comparison of three different organ failure assessment score systems in predicting outcome of severe sepsis].
Luo XP; Wang HH; Hu SF; Wu SJ; Xie GH; Cheng BL; Zhou C; Fang XM
Zhonghua Wai Ke Za Zhi; 2009 Jan; 47(1):48-50. PubMed ID: 19484951
[TBL] [Abstract][Full Text] [Related]
14. Cost-effectiveness of activated protein C in real-life clinical practice.
Dhainaut JF; Payet S; Vallet B; França LR; Annane D; Bollaert PE; Le Tulzo Y; Runge I; Malledant Y; Guidet B; Le Lay K; Launois R;
Crit Care; 2007; 11(5):R99. PubMed ID: 17822547
[TBL] [Abstract][Full Text] [Related]
15. Serum IL-6 and IL-1-ra with sequential organ failure assessment scores in septic patients receiving high-volume haemofiltration and continuous venovenous haemofiltration.
Ghani RA; Zainudin S; Ctkong N; Rahman AF; Wafa SR; Mohamad M; Manaf MR; Ismail R
Nephrology (Carlton); 2006 Oct; 11(5):386-93. PubMed ID: 17014550
[TBL] [Abstract][Full Text] [Related]
16. Use of protein C concentrate in pediatric patients with sepsis.
Silvani P; Camporesi A; Licari E; Wolfler A
Minerva Anestesiol; 2005 Jun; 71(6):373-8. PubMed ID: 15886604
[TBL] [Abstract][Full Text] [Related]
17. The current management of septic shock.
Russel JA
Minerva Med; 2008 Oct; 99(5):431-58. PubMed ID: 18971911
[TBL] [Abstract][Full Text] [Related]
18. [Two cases of severe sepsis successfully treated with activated protein C].
Aguirre Caballero A; Gutiérrez-Jodra Gamboa A; García Pérez Del Río JI; Lavilla Díaz M
Rev Esp Anestesiol Reanim; 2003 Dec; 50(10):539-43. PubMed ID: 14737782
[TBL] [Abstract][Full Text] [Related]
19. Epidemiology of severe sepsis in intensive care units in the Slovak Republic.
Záhorec R; Firment J; Straková J; Mikula J; Malík P; Novák I; Zeman J; Chlebo P
Infection; 2005 Jun; 33(3):122-8. PubMed ID: 15940412
[TBL] [Abstract][Full Text] [Related]
20. Relation of heart rate variability to serum levels of C-reactive protein, interleukin 6, and 10 in patients with sepsis and septic shock.
Papaioannou VE; Dragoumanis C; Theodorou V; Gargaretas C; Pneumatikos I
J Crit Care; 2009 Dec; 24(4):625.e1-7. PubMed ID: 19327330
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
